Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Malignant gliomas: new translational therapies.

Sul J, Fine HA.

Mt Sinai J Med. 2010 Nov-Dec;77(6):655-66. doi: 10.1002/msj.20223. Review.

PMID:
21105127
2.

Molecularly targeted therapy for malignant glioma.

Sathornsumetee S, Reardon DA, Desjardins A, Quinn JA, Vredenburgh JJ, Rich JN.

Cancer. 2007 Jul 1;110(1):13-24. Review.

3.

New treatment strategies for malignant gliomas.

Sathornsumetee S, Rich JN.

Expert Rev Anticancer Ther. 2006 Jul;6(7):1087-104. Review.

PMID:
16831080
4.

Antiangiogenic therapy in malignant glioma: promise and challenge.

Sathornsumetee S, Rich JN.

Curr Pharm Des. 2007;13(35):3545-58. Review.

PMID:
18220791
5.

Biologic principles of immunotherapy for malignant gliomas.

Han SJ, Kaur G, Yang I, Lim M.

Neurosurg Clin N Am. 2010 Jan;21(1):1-16. doi: 10.1016/j.nec.2009.08.001. Review.

PMID:
19944962
6.

Chemotherapeutic options for primary brain tumors.

Kim L, Glantz M.

Curr Treat Options Oncol. 2006 Nov;7(6):467-78. Review.

PMID:
17032559
7.

Novel therapies for malignant gliomas.

Cavaliere R, Wen PY, Schiff D.

Neurol Clin. 2007 Nov;25(4):1141-71, x. Review.

PMID:
17964029
8.

Immunotherapeutic strategies for malignant glioma.

Fenstermaker RA, Ciesielski MJ.

Cancer Control. 2004 May-Jun;11(3):181-91. Review.

9.

Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.

Lefranc F, Rynkowski M, DeWitte O, Kiss R.

Adv Tech Stand Neurosurg. 2009;34:3-35. Review.

PMID:
19368079
10.

Dendritic cell-based immunotherapy for malignant gliomas.

Akasaki Y, Black KL, Yu JS.

Expert Rev Neurother. 2005 Jul;5(4):497-508. Review.

PMID:
16026233
11.

Chemotherapy and novel therapeutic approaches in malignant glioma.

Desjardins A, Rich JN, Quinn JA, Vredenburgh J, Gururangan S, Sathornsumetee S, Reardon DA, Friedman AH, Bigner DD, Friedman HS.

Front Biosci. 2005 Sep 1;10:2645-68. Review.

PMID:
15970525
12.
13.
14.

Molecular advances of brain tumors in radiation oncology.

Noda SE, El-Jawahri A, Patel D, Lautenschlaeger T, Siedow M, Chakravarti A.

Semin Radiat Oncol. 2009 Jul;19(3):171-8. doi: 10.1016/j.semradonc.2009.02.005. Review.

PMID:
19464632
15.

Exploitation of immune mechanisms in the treatment of central nervous system cancer.

Pollack IF, Okada H, Chambers WH.

Semin Pediatr Neurol. 2000 Jun;7(2):131-43. Review.

PMID:
10914414
16.

Cancer stem cells and malignant gliomas. From pathophysiology to targeted molecular therapy.

Florian IS, Tomuleasa C, Soritau O, Timis T, Ioani H, Irimie A, Kacso G.

J BUON. 2011 Jan-Mar;16(1):16-23. Review.

PMID:
21674845
17.

Dendritic-cell- and peptide-based vaccination strategies for glioma.

Yamanaka R.

Neurosurg Rev. 2009 Jul;32(3):265-73; discussion 273. doi: 10.1007/s10143-009-0189-1. Epub 2009 Feb 13. Review.

PMID:
19214609
18.

Principles of treatment of malignant gliomas in adults: an overview.

Azizi SA, Miyamoto C.

J Neurovirol. 1998 Apr;4(2):204-16. Review.

PMID:
9584957
19.

Malignant gliomas.

Burton EC, Prados MD.

Curr Treat Options Oncol. 2000 Dec;1(5):459-68. Review.

PMID:
12057153
20.

Biomarkers of clinical responsiveness in brain tumor patients : progress and potential.

El-Jawahri A, Patel D, Zhang M, Mladkova N, Chakravarti A.

Mol Diagn Ther. 2008;12(4):199-208. Review.

PMID:
18652516

Supplemental Content

Support Center